Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0TE6A
|
|||
Former ID |
DNC004291
|
|||
Drug Name |
1,5-Dihydro-imidazo[2,1-b]quinazolin-2-one
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
![]() |
Download2D MOL |
||
Canonical SMILES |
C1C2=CC=CC=C2NC3=NC(=O)CN31
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Phosphodiesterase 3A (PDE3A) | Target Info | Inhibitor | [1] |
KEGG Pathway | Purine metabolism | |||
cGMP-PKG signaling pathway | ||||
cAMP signaling pathway | ||||
Morphine addiction | ||||
Reactome | cGMP effects | |||
G alpha (s) signalling events | ||||
WikiPathways | miR-targeted genes in muscle cell - TarBase | |||
miR-targeted genes in lymphocytes - TarBase |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoim... J Med Chem. 1988 Nov;31(11):2136-45. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.